Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
2.655
+0.085 (3.31%)
Mar 4, 2026, 4:00 PM EST - Market closed
Absci Market Cap
Absci has a market cap or net worth of $399.99 million as of March 4, 2026. Its market cap has decreased by -40.16% in one year.
Market Cap
399.99M
Enterprise Value
261.25M
1-Year Change
-40.16%
Ranking
Category
Stock Price
$2.66
Market Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has decreased from $423.19M to $399.99M, a decrease of -5.48%. That is a compound annual growth rate of -1.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 386.45M | -26.36% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
| Jul 22, 2021 | 423.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Century Therapeutics | 414.99M |
| Upstream Bio | 413.40M |
| Entrada Therapeutics | 413.28M |
| LENZ Therapeutics | 411.15M |
| Enanta Pharmaceuticals | 410.91M |
| DiaMedica Therapeutics | 410.41M |
| Immutep | 404.21M |
| Niagen Bioscience | 402.05M |